Generic Drug Case Law
Tuesday, November 9, 2021
2:30 p.m. - 3:30 p.m.
Join lawyers from industry to discuss recent court rulings affecting generic drug development, including those related to IP protections and FDA regulatory review. Discussion will include new challenges brought on by court rulings, how Congress or the executive branch could respond and the impact on generic drug availability for patients and providers.
Moderator: Karin Hessler, JD
Vice President, IP Policy & Deputy General Counsel, AAM
Brian McCormick, JD
Vice President & Chief Regulatory Counsel Head, Global Regulatory Policy, Teva Pharmaceuticals
Michael Shumsky, JD
Director, Hyman, Phelps & McNamara